Images
El Punt Avui, Al Día, Noticias de la Ciencia, Catalunya Press, among other media, have published an article about a study led by Manuel Serrano, leader of the Laboratory of Cellular Plasticity and Disease at IRB Barcelona, which establishes therapeutic opportunities to eliminate senescent cells in diseases such as cancer.
Link to El Punt Avui
Link to Al Día
Link to Noticias de la Ciencia
Link to Catalunya Press
About IRB Barcelona
The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).
